Antithrombin to prevent blood clots after serious trauma
Part of Heart & circulation, Injuries & trauma clinical trials.
This Phase 2 trial studies whether giving antithrombin can better prevent harmful blood clots (venous thromboembolism) after serious injuries. The goal is to reduce clot risk while you’re in the trauma ICU or step-down unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are admitted to the trauma team (for serious injury).
- You have multiple injuries or a pelvic or long-bone fracture.
- You expect to be cared for in the trauma ICU or a step-down unit.
- You (or your legal representative) can give informed consent.
- You must not be in another treatment study at the same time (unless the trial doctor approves).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two doses of a blood thinner (enoxaparin) to see which better prevents blood clots in patients with severe injuries who are in the intensive care unit. It helps doctors choose the best dose to keep you safe and healthy.
This trial compares giving whole blood versus standard care in adults with severe trauma and dangerous blood loss (hemorrhagic shock). The goal is to see if whole blood helps stabilize patients faster and improves outcomes after major bleeding.
This trial tests whether giving tranexamic acid (TXA), a medicine that helps blood clot, reduces death and disability in children who have bleeding after a severe injury. It is given within 3 hours of the injury, and could help children with head or torso trauma who are at risk of serious bleeding.
This study tests an investigational treatment called INTERCEPT Fibrinogen Complex (IFC) for people with severe bleeding after a traumatic injury. The treatment helps restore a key blood-clotting protein to try to stop the bleeding and improve survival.
This trial tests whether taking an anti–blood clot medicine (dalteparin) and using leg compression can reduce dangerous blood clots after a severe traumatic brain injury. It may help lower the chance of clots forming when people are immobile and at higher risk.
This study looks back at patient records to see how antithrombin (a medicine that helps prevent blood clots) was used in intensive care or during surgery. It does not test a new treatment, but helps doctors understand if the medicine was given appropriately.
Hear when a new Trauma Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.